American National Bank & Trust’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$314K Sell
1,612
-10
-0.6% -$2.07K 0.03% 194
2026
Q1
$364K Sell
1,622
-25
-2% -$6.23K 0.03% 171
2025
Q4
$397K Sell
1,647
-26
-2% -$6.65K 0.04% 169
2025
Q3
$458K Sell
1,673
-49
-3% -$13.4K 0.05% 160
2025
Q2
$444K Sell
1,722
-191
-10% -$45.6K 0.05% 178
2025
Q1
$428K Sell
1,913
-330
-15% -$77K 0.05% 161
2024
Q4
$513K Sell
2,243
-60
-3% -$14.4K 0.06% 138
2024
Q3
$562K Sell
2,303
-103
-4% -$23K 0.07% 128
2024
Q2
$461K Sell
2,406
-10
-0.4% -$2.03K 0.06% 141
2024
Q1
$478K Sell
2,416
-887
-27% -$163K 0.06% 139
2023
Q4
$568K Buy
3,303
+3,080
+1,381% +$473K 0.09% 114
2023
Q3
$33K Sell
223
-4,165
-95% -$753K 0.01% 316
2023
Q2
$959K Buy
4,388
+1,552
+55% +$346K 0.16% 79
2023
Q1
$621K Buy
2,836
+2,821
+18,807% +$612K 0.11% 97
2022
Q4
$3K Sell
15
-4
-21% -$879 ﹤0.01% 470
2022
Q3
$4K Sell
19
-1,202
-98% -$274K ﹤0.01% 437
2022
Q2
$256K Sell
1,221
-40
-3% -$8.52K 0.06% 105
2022
Q1
$306K Sell
1,261
-4,866
-79% -$1.18M 0.06% 106
2021
Q4
$1.6M Sell
6,127
-274
-4% -$71.1K 0.31% 65
2021
Q3
$1.69M Buy
6,401
+8
+0.1% +$2.19K 0.37% 50
2021
Q2
$1.58M Buy
6,393
+1,601
+33% +$337K 0.34% 52
2021
Q1
$930K Buy
4,792
+4,772
+23,860% +$957K 0.22% 75
2020
Q4
$4K Buy
+20
New +$3.99K ﹤0.01% 206

Other funds holding RMD

American National Bank & Trust's RMD Position: Q2 2026 in Review

American National Bank & Trust reduced its ResMed (RMD) stake by 0.62% in Q2 2026, selling an estimated $2.07K and leaving 1,612 shares worth $314K. The position accounts for 0.03% of the portfolio, ranked #194.

American National Bank & Trust first reported a position in RMD in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.69M in Q3 2021. 199 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • American National Bank & Trust held 1,612 shares of ResMed worth $314K as of Q2 2026.
  • American National Bank & Trust sold 10 ResMed shares in Q2 2026, an estimated $2.07K.
  • ResMed made up 0.03% of American National Bank & Trust's portfolio in Q2 2026, its #194 holding.
  • American National Bank & Trust first reported a position in ResMed in Q4 2020 and has held it in 23 quarters since.
  • American National Bank & Trust's ResMed position peaked at $1.69M in Q3 2021.
  • 199 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.